Medlab Asia & Asia Health’s Post

Exciting News! Hamilton is proud to announce our strategic partnership with Labor Berlin to advance the automation and standardization of laboratory workflows in sample preparation. Together, we are addressing the daily challenges of IVD-R-compliant, laboratory-developed workflows across diverse sample matrices, including chromatographic, immunological, and molecular diagnostic analyses. Key highlights of our partnership: 🔹 Integration of Hamilton's STAR platform and the innovative VENUS software. 🔹 Optimized workflows through parallelized processes tailored to varying sample quantities and diagnostic requirements. 🔹 Enhanced traceability, streamlined workflows, and reduced error rates, ultimately leading to improved patient safety and health. With the increased demands of IVD regulations, Labor Berlin - Charité Vivantes GmbH, as Europe’s largest hospital laboratory, is committed to providing top-tier diagnostic services for Charité – Universitätsmedizin Berlin, all Vivantes – Netzwerk für Gesundheit clinics, and numerous other outpatient care physicians. Our extensive experience in automating clinical laboratory workflows will significantly contribute to our shared goal of setting new standards in laboratory automation. Learn more about how this partnership is setting new standards in laboratory automation and enhancing diagnostic services here: https://lnkd.in/dDHg5kAh #Hamilton #LaborBerlin #LaboratoryAutomation #IVDR #DiagnosticServices #HealthcareInnovation #PatientSafety

Immersed in the Future: Insights from the "Current Status and Future Perspectives of Precision Medicine" Seminar! Recently wrapped up an incredibly enriching two days at the "Current Status and Future Perspectives of Precision Medicine" seminar, and I'm buzzing with excitement about the transformative impact it holds for the future of healthcare! Key Learnings: Cutting-edge Technologies: Explored the latest technologies driving precision medicine, from genomic sequencing to advanced diagnostics, opening new frontiers in personalized patient care. Clinical Applications: Delved into real-world case studies showcasing how precision medicine is revolutionizing treatment strategies and improving patient outcomes across various medical specialties. Ethical Considerations: Explored the ethical implications of precision medicine, engaging in thought-provoking discussions about privacy, consent, and equitable access to these groundbreaking therapies. Collaboration Opportunities: Connected with experts and enthusiasts in the field, fostering collaborations that promise to push the boundaries of precision medicine research and implementation. To my fellow healthcare professionals and enthusiasts, precision medicine is not just a buzzword—it's a game-changer. This seminar provided a comprehensive overview of its current status and a glimpse into the exciting future it promises. A heartfelt thank you to the organizers for curating such an informative and thought-stimulating event! Your dedication to advancing the field of precision medicine is truly commendable. Excited to apply these insights to elevate patient care and contribute to the future of medicine! #precisionmedicine #healthcareinnovation #FutureOfMedicine #SeminarHighlights #networkingopportunities

Celebrating the Precision Medicine Initiative (PMI): A Leap Forward in Personalized Healthcare Eight years ago, today, the The White House hosted the Precision Medicine Initiative Summit, a landmark event in healthcare evolution. President Barack Obama's address highlighted the initiative's mission to revolutionize medicine. He focused on the individuality of diseases such as cancer, noting the need for personalized treatments and more efficient healthcare systems. A fundamental element of the PMI has been developing extensive, interconnected databases. By merging electronic medical records with robust privacy safeguards, we've facilitated effective collaboration among researchers and healthcare professionals. This partnership is vital for accelerating treatment discoveries, especially for complex diseases like cancer and Alzheimer's. My role in initiating and leading precisionFDA at the FDA in 2015 was integral to this initiative, which has since attracted significant support from various sectors. This broad-based support reflects a unified commitment to advancing precision medicine. The United States, with its legacy of innovation and research, is perfectly suited to lead this transformative journey. We are working towards a future where personalized medicine is not just an aspiration but a standard, fundamentally reshaping healthcare for future generations. Robert Califf, David Litwack, Elizabeth Mansfield, Sally Howard, Zivana Tezak #PrecisionMedicine #ObamaLegacy #HealthcareInnovation #precisionFDA #FutureOfHealthcare #PMI

Yup - #KRASholes are a world wide problem!! Those barriers, gaps in Healthcare Outcomes Literacy & Equity we know they exist, I'm delighted to be on this Global Summit with difference makers! Join me on May 1st for an open panel discussion to address these holes the advancement of precision medicine. This virtual global summit will share and open for discussion the solutions and recommendations proposed by the ‘Precision Medicine Practice Gaps Economic, Policy and Operational Solutions Forum’. Composed of leading experts in the precision medicine field, our shared aim is to provide the industry and policy makers with valuable and clear economic guidance and recommendations to overcome the challenges obstructing the advancement of precision medicine. Register for free using the link https://lnkd.in/edPcGVNX #PrecisionMedicine #KnowKRAS #HealthcareInnovation

Yesterday, during the Global Summit on Precision Medicine, we had a thought-provoking discussion. Now, it's time for all attendees and those committed to personalized medicine to take action on our findings regarding current practice gaps. These gaps keep patients from receiving necessary treatments and care, and we must implement our recommendations to improve health for all. Together, we can make a difference. Thanks to my co-chair Susanne Munksted, Peter Keeling, the Diaceutics PLC team, our Forum members, and guest panelists for making a great event. We have a rich set of data and recommendations to utilize now. #rednucleus #personalizedmedicine #precisiondiagnostics #personalizedmedicinecoalition

It's 18 months since JCO published the Clinical Practice Gaps paper that delivered the astounding statistic that 64% of patients do not gain access to optimal precision therapies. Diaceutics are hosting a landmark, free-to-attend, summit on May 1st to discuss how all stakeholders can come together to address the economic, policy and operational barriers that are impacting patient lives. I hope you can join us for this important discussion on how together we can shape the future of precision medicine. https://lnkd.in/e8yUFxRB #JoinThePanel #PrecisionMedicine

DPHARM is one of my favorite conferences for the industry as it focuses on innovation, new voices, and progress. I love connecting with fellow attendees, please reach out if you'll be in Philly! #clinicalresearch #distruption #innovation #clinicaltrials #drugdevelopment DPHARM: Disruptive Innovations to Modernize Clinical Research

It's #ClinicalTrialsDay in the USA! Let's celebrate the heroes of medical progress who work tirelessly to change outcomes for patients worldwide. Clinical trials are the engines driving innovation in healthcare. They allow us to test new treatments and therapies, paving the way for a healthier future for all. Today, we recognize the incredible dedication of the brilliant researchers who design and oversee these trials, and the participants who give the ultimate gift to patients. 👀 Have you seen our list of #radiotherapeutics under clinical development? At the foundation, we are committed to sharing the status of radiotherapeutic molecules from their early stages. Check it out here: https://buff.ly/3Xr8Sjc #CancerResearch #CancerAwareness

Health Technology Wales has announced that millions have been invested in eight innovative companies that are developing life-saving medical technologies. These cutting-edge devices have the potential to tackle some of the most challenging health issues we face today. With focused ultrasound waves by HistoSonics, Inc., which aim to identify and destroy liver cancer tumours, Roche Diagnostics UK & Ireland's blood test for Alzheimer’s Disease which means patients could be treated earlier, and Upfront Diagnostics's portable blood test which could help paramedics identify stroke patients more quickly, early interventions are within reach. This funding, part of the government's Innovative Devices Access Pathway (IDAP) initiative, fuels innovation and aims to bring state-of-the-art technologies and solutions to the forefront of the NHS. These advancements could have transformative impacts on patient care and signify a new era of medical innovation. Read more: https://lnkd.in/e-pgXK7f #Innovation #HealthInnovation #LifeSciences Marc Bailey Medicines and Healthcare products Regulatory Agency NICE - National Institute for Health and Care Excellence Jeanette Kusel Vin Diwakar EarSwitch Avegen Presymptom Health Susan Myles

Join us for an exclusive webinar! Come discover the 9 protocol advantages of the Spectra Optia Apharesis System. Our seasoned professionals will delve deep into the benefits and applications of this cutting-edge technology, providing valuable insights. Are you an Oncologist, a Haematologist, Laboratory scientist, Cardiologist, or healthcare enthusiast? this webinar is tailor-made for you! Kindly register using this link: https://lnkd.in/diihjE2f #Sudabelt #SudabeltMedical #MedicalEquipment #MedicalSupplier #SudabeltWebinar #Webinar